Accuracy of sentinel lymph node in papillary thyroid carcinoma

被引:43
作者
Arch-Ferrer, J [1 ]
Valázquez, D [1 ]
Fajardo, R [1 ]
Gamboa-Domínguez, A [1 ]
Herrera, MF [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Surg, Mexico City 11000, DF, Mexico
关键词
D O I
10.1067/msy.2001.118372
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The sentinel lymph node has been used in several tumors. The aim of this study was to analyze the accuracy of sentinel mode in papillary thyroid carcinoma. Methods. A series of 22 patients with papillary thyroid carcinoma were included. Approximately 0.5 cc of isosulfan blue dye was injected at operation to trace the sentinel node. Lymph node dissection of the ipsilateral central compartment and extensive sampling of the jugular compartment were performed in addition to sentinel node resection. Surgical specimens were stained with hematoxylin-eosin, and negative sentinel nodes were subsequently stained with immunohistochemistry for cytokeratin-7. Results. Mean age was 37 +/- 14 years. Twenty patients were women, and 2 were men. Mean tumor size was 2.5 +/- 1 cm. A sentinel lymph node was found in 20 patients. With use of hematoxylin-eosin, metastases were identified in 12/20 sentinel nodes (60%). Eleven patients with positive sentinel nodes presented additional lymph node metastases: 9 in the central compartment, 1 in the jugular compartment, and 1 in both compartments. Two patients with negative sentinel nodes had lymph node metastases elsewhere. When sentinel nodes were processed by immunohistochemistry, accuracy increased to 100%. Conclusions. Sentinel node is highly accurate for diagnosing metastases in papillary thyroid carcinoma.
引用
收藏
页码:907 / 913
页数:7
相关论文
共 26 条
[1]   Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms [J].
Bejarano, PA ;
Nikiforov, YE ;
Swenson, ES ;
Biddinger, PW .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2000, 8 (03) :189-194
[2]   Presidential address: Beyond risk groups - A new look at differentiated thyroid cancer [J].
Cady, B .
SURGERY, 1998, 124 (06) :947-957
[3]   Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms [J].
Dixon, E ;
McKinnon, JG ;
Pasieka, JL .
WORLD JOURNAL OF SURGERY, 2000, 24 (11) :1396-1401
[4]   Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? [J].
Hay, ID ;
Grant, CS ;
Bergstralh, EJ ;
Thompson, GB ;
van Heerden, JA ;
Goellner, JR .
SURGERY, 1998, 124 (06) :958-964
[5]  
HAY ID, 1993, SURGERY, V114, P1050
[6]   Papillary thyroid carcinoma in Mexican patients: Clinical aspects and prognostic factors [J].
Herrera, MF ;
LopezGraniel, CM ;
Saldana, J ;
GamboaDominguez, A ;
RichaudPatin, Y ;
VargasVorackova, F ;
AngelesAngeles, A ;
Llorente, L ;
Castillo, C ;
Perez, B ;
Rivera, R ;
Gonzalez, O ;
Rull, J .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :94-100
[7]  
Johnson LW, 1999, J SURG ONCOL, V70, P100, DOI 10.1002/(SICI)1096-9098(199902)70:2<100::AID-JSO7>3.0.CO
[8]  
2-T
[9]   Differentiated thyroid cancer: "Complete" rational approach [J].
Kebebew, E ;
Clark, OH .
WORLD JOURNAL OF SURGERY, 2000, 24 (08) :942-951
[10]   Sentinel lymphadenectomy in thyroid malignant neoplasms [J].
Kelemen, PR ;
Van Herle, AJ ;
Giuliano, AE .
ARCHIVES OF SURGERY, 1998, 133 (03) :288-292